LIPODERMA Trademark
Trademark Overview
On Wednesday, October 9, 2024, a trademark application was filed for LIPODERMA with the United States Patent and Trademark Office. The USPTO has given the LIPODERMA trademark a serial number of 98792318. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, November 27, 2024. This trademark is owned by Britecyte Inc.. The LIPODERMA trademark is filed in the Pharmaceutical Products category with the following description:
Human allograft tissue
General Information
Serial Number | 98792318 |
Word Mark | LIPODERMA |
Filing Date | Wednesday, October 9, 2024 |
Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
Status Date | Wednesday, November 27, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Human allograft tissue |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, October 9, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Britecyte Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Frederick, MD 21703 |
Trademark Events
Event Date | Event Description |
Wednesday, October 9, 2024 | NEW APPLICATION ENTERED |
Wednesday, October 9, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, November 21, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, November 21, 2024 | ASSIGNED TO EXAMINER |